Search Results - "Pei, Jingjun"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Umbilical cord blood cell characteristics in very preterm neonates for autologous cell therapy of preterm-associated complications by Zhuxiao, Ren, Jiangxue, Han, Yongsheng, Li, Jingjun, Pei, Shuo, Yang, Fang, Xu, Qi, Zhang, Shandan, Zhang, Chuan, Nie, Jie, Yang

    Published in BMC pediatrics (25-03-2024)
    “…There are emerging clinical evidence for umbilical cord blood mononuclear cells (UCBMNCs) intervention to improve preterm complications. The first critical…”
    Get full text
    Journal Article
  2. 2

    Effect of blood sampling management on reducing blood transfusions in very preterm infants by Pei, Jingjun, Tang, Jun, Hu, Yanling, Wan, Xingli, Shi, Jing, Wang, Hua, Chen, Qiong, Li, Xiaowen, Chen, Jian, Chen, Chao, Chen, Hongju, Ying, Junjie, Mu, Dezhi

    Published in Chinese medical journal (05-10-2023)
    “…[1] RBCTs are increasingly reported to cause inflammatory responses and increase the incidence of preterm complications. [...]reducing iatrogenic blood loss…”
    Get full text
    Journal Article
  3. 3

    Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study by Zhang, Meng, He, Yang, Tang, Jun, Dong, Wenbin, Zhang, Yong, Zhang, Benjin, Wan, Hong, Deng, Quanmin, Guan, Lirong, Xia, Bin, Chen, Zhong, Ge, Min, Zhao, Jing, Li, Wenxing, Pei, Jingjun, Qu, Yi, Mu, Dezhi

    Published in Chinese medical journal (15-02-2022)
    “…Intensive phototherapy (IPT) and exchange transfusion (ET) are the main treatments for extreme hyperbilirubinemia. However, there is no reliable evidence on…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Antimicrobial peptide LL37 and regulatory T cell associated with late-onset sepsis in very preterm infants by Zhuxiao, Ren, Shuo, Yang, Jiangxue, Han, Jingjun, Pei, Qi, Zhang, Zhu, Wang, Fang, Xu, Jie, Yang

    Published in iScience (17-05-2024)
    “…Stem cell therapy may prevent late-onset sepsis (LOS) via antimicrobial peptide LL37 secretion and regulatory T cell (Treg) regulation. The early prediction of…”
    Get full text
    Journal Article
  8. 8